to 16°C and 1 hour later the protein expression was induced overnight by adding isopropyl-1-thio-β-galactoside (IPTG) to a final concentration of 0.5mM.
Lysis of cells was done by sonication in 75ml of buffer A (50mM TrisHCl pH8, 250mM
NaCl, 5% glycerol, 5mM βmercaptoethanol) and cellular debris were sedimented by centrifugation of the lysate during 30 minutes at 40000g. The supernatant was incubated 3 hours at 277K with 3ml of glutathione sepharose media (Amersham Biotech). After a short centrifugation, the supernatant was discarded and the beads were poured on a glass Econocolumn (Bio-Rad Laboratories, USA). The column was washed twice with 15ml of buffer A and the protein was eluted with 20 ml of buffer A + 10mM glutathione. Cleavage of the GST part was done overnight at 277K with 1u of thrombin (SIGMA) per mg of protein. The protein was then concentrated with a Centriprep-10 concentrator (Amicon, USA), loaded on a gel filtration column (HiLoad 16/60 Superdex S75, Amersham Biotech) and eluted at 0.5ml/min with buffer B (20mM TrisHCl pH8, 50mM NaCl, 5mM βmercaptoethanol). The elution volume of CARM1 corresponds to an apparent molecular weight of roughly 24000 Da, as estimated after calibration of the gel filtration column with molecular weight markers (Bio-Rad Laboratories, USA). Fractions containing CARM1 28-140 were pooled and concentrated at 4 mg/ml. The purity of the protein was verified by electrophoresis (SDS gel 15% and native gel 8-25%). Only one protein band was seen on both types of gel (data not shown). Typically 6mg of purified protein were obtained from one litre culture.
CARM1 28-140 : mass spectrometry
Prior to ESI-MS analysis, the sample was dialyzed using mini-dialysis unit (Slide-A-Lyser, Pierce) against 100 mM ammonium acetate, pH 7. For experiments in denaturing conditions, proteins were diluted in a 1:1 water-acetonitrile mixture (v/v) acidified with 1% formic acid to achieve a concentration of 5 pmol/µL. For experiments in native conditions, samples were diluted to 20 pmol/µL in 50 mM ammonium acetate, pH 6.5. Mass spectrometric studies were performed in the positive ion mode using a commercially available time-of-flight mass spectrometer (LCT, Waters, MA), fitted with a z-spray source. Sample solutions were introduced into the mass spectrometer source with a syringe pump (Harvard Type 55 1111, Harvard Apparatus, South Natick, MA, USA) with a flow-rate of 5 µL/min. Calibration was performed using protonated horse heart myoglobin (SIGMA). To convey intact non-covalent complexes from solution to the gas phase without fragmentation, the accelerating cone voltage (Vc) and the pressure (P) in the "interface region", were carefully optimized.
The electrospray ionization (ESI) mass spectrum obtained for CARM1 under denaturing conditions is shown in Supplementary Figure 1A . The series of charged peaks observed show that the protein sample is pure and homogenous. The calculated mass from the spectrum is 12833.2 ±0.14 Da which is in good agreement with the calculated mass of the monomer (12832.6 Da).
The mass spectrum obtained for CARM1 under native conditions is shown in Supplementary Figure 1B . Two series of three multiply charged peaks (multiply charged ions with 7 to 9 and 10 to 12 protonations respectively) are observed. The minor series of peaks correspond to trace amount of the monomer. The molecular weight determined from the second series is 25667.24 ± 0.87 Da, which is in good agreement with the calculated mass of the dimer (25665.2 Da).
CARM1 28-140 : analytical ultracentrifugation
Sedimentation equilibrium experiments were carried out at 4°C with a Beckman Optima XLA analytical ultracentrifuge equipped with a four-hole An-55 rotor and standard 1.2-cm hexasector cells. The protein was concentrated at 2mg/ml in 50mM TrisHCl pH8, 50mM NaCl.
The sample was run at 20000 rpm. Protein concentration distributions were determined by absorption at 280 nm. Data were collected over a 22-h period. After centrifugation for 12 h, scans were compared at 2-h intervals to ensure that equilibrium had been reached. Sedimentation equilibrium analysis was performed using the program SEDPHAT (SEDimentation and Polymer Hydrodynamic Analysis Tool) (Schuck, 2000) . The data, absorbance versus radial distance, were analysed using the fitting models for a single homogeneous species. The solvent density (1.00172 g/ml) and the partial specific volume of CARM1 (0.7287 ml/g) were calculated with the program SEDNTERP (Lee & Bedford, 2002) . Data are in good agreement with a single homogeneous species with a molecular weight of 25137 Da, which corresponds to a dimer (expected mass of 25665 Da), see
CARM1 28-140 : buffer condition optimization prior to crystallization
In order to determine a buffer that gives the most homogeneous protein sample, the screeningsolubility method described by Jancarik et al (2004) was used. CARM1 28-140 was concentrated to 10 mg/ml in 25 mM TrisHCl pH8, 30 mM NaCl. Vapor diffusion drops were set by mixing 2μl of protein solution with 2μl of a buffer solution at 100 mM and equilibrated overnight at 277K against 1ml reservoir consisting of the buffer solution. 21 different buffers between pH=4 and pH=9.5 were tested. Clear drops were diluted with 14µl of the reservoir solution prior to Dynamic Light scattering analysis performed using a DynaPro-MS (Protein Solutions, USA). The polydispersity of the protein was minimal in Imidazole pH6.2 (Cp/Rh = 11%).
Prior to crystallization trials, CARM1 28-140 was dialyzed against 50mM Imidazole pH6.2, 1mM Tris(2-CarboxyEthyl) phosphine (TCEP).
CARM1 28-140 : crystallization and data collection
Crystallization conditions were screened using commercially available kits by the sitting-drop vapor-diffusion method in 96-well CrystalQuick plates (Greiner Bio-One), employing a Tecan robot. First hits were obtained with the Index screen (Hampton research, USA). After optimization, needle shaped crystals (600x50x30 µm) suitable for X-ray diffraction grew in a few days in hanging drops made by mixing 2 µl of protein solution at 4 mg/ml and 1 µl of reservoir solution consisting of 13%-16%(w/v) peg6000, 100mM TrisHCl pH8 and 30-60mM ammonium sulfate. Drops were equilibrated against 0.5 ml of reservoir solution at 277K. Table I .
Single isomorphous replacement method and anomalous scattering from one heavy-atom derivative (trimethyl lead acetate, TMLA) was used to solve the phases problem. Prior to heavy atoms soaking, native crystals were transferred into pre-equilibrated drops containing 1 µl of the reservoir solution (15%(w/v) peg 6000, 0.1 M Hepes pH 7.5, 10 mM ammonium sulfate) and 1 µl of protein (4 mg/ml in 50mM Imidazole pH6.2) for 24h. 1 µl of a solution of 1mM trimethyl lead acetate was then added to the drops and crystals were allowed to incubate for 4h. Soaked crystals were cryoprotected by a short wash in 18%(w/v) peg 6000, 0.1 M Hepes pH 7.5, 10 mM ammonium sulfate and 15% PEG 400 and flash-cooled in liquid nitrogen. X-ray diffraction data were collected using a single cryo-cooled ( 
CARM1 28-140 : structure determination
Phases to 2.8 Å were obtained using single isomorphous replacement method and anomalous scattering from one heavy-atom derivative (trimethyl lead acetate) and followed by solventflattening procedure with SOLVE/RESOLVE (Terwilliger & Berendzen, 1999) . The phasing process allowed the determination of the correct space group (P4 1 2 1 2 versus P4 3 2 1 2). The modified 2.8 SIRAS map allowed chain tracing for most parts of the two polypeptide chains.
The final model contains two copies, designated as molecules A and B, respectively. A few regions of the polypeptide are not visible in the electron density map and are assumed to be disordered namely residues 132-140 and residues 41-50 for molecule B. The current refined model has a crystallographic R-factor of 20.5% (Rfree=25.5%) at 1.7 Å (see Table I for detailed statistics).
CARM 28-507 : structure determination
Phases to 3.1 Å were obtained by multiple isomorphous replacement method and anomalous scattering from two heavy-atom derivatives (trimethyl lead acetate and xenon) and followed by solvent-flattening procedure with SOLVE/RESOLVE (Terwilliger & Berendzen, 1999) .
The crystals belong to the hexagonal space group P6 2 22 with unit cell parameters Crystal packing contains large unoccupied regions that can easily fit the missing PH domains (residue 28-130, data not shown). The current refined model has a crystallographic R-factor of 23.0% (Rfree=26.9%) at 2.55 Å resolution (see Table I for detailed statistics).
The absence of residues 28-146 in the electron density map of CARM1 crystals prompted us to carefully analyze the content of crystals in order to exclude proteolysis of the protein during the crystallization process. This has been done by four different techniques: SDS polyacrylamide gel electrophoresis, amino-terminal sequencing and MALDI mass spectrometry analysis on the purified protein and on dissolved crystals, and mass spectrometry under denaturing conditions on the purified protein (Supplementary Figure 3) .
Mass spectrometry of CARM 28-507
Prior to ESI-MS analysis, the sample was dialyzed using mini-dialysis unit (Slide-A-Lyser, Pierce) against 100 mM ammonium acetate, pH 7 and the protein was diluted in a 1:1 wateracetonitrile mixture (v/v) acidified with 1% formic acid to achieve a concentration of 5 pmol/µL. The analysis was done as described above for CARM . The mass spectrum obtained for CARM in denaturing conditions is shown in Supplementary Figure 3B . The molecular weight determined from the mass spectrum is 54313.9 ± 2.76 Da, which is in good agreement with the calculated mass (54311.8 Da) of CARM .
N-terminal sequencing of CARM 28-507 crystals
Several crystals were collected with a nylon cryoloop, washed twice in 5 µl of reservoir solution and dissolved in SDS-PAGE loading buffer. Samples for sequencing were run on a 10% acrylamide SDS gel and electroblotted onto a Hybond-P polyvinylidene difluoride (PVDF) membrane (Amersham Biosciences) according to (Henzel et al, 1999) . Protein transfer was done for 90 minutes at 1 mA/cm 2 . After staining with Coomassie blue, the bands of interest were excised and subjected to N-terminal sequencing by automated Edman's degradation using an Applied Biosystems Protein Sequencer Procise 492/610A. The method identifies the presence of the peptide SHMA 28 T 29 V 30 S 31 V 32 F 33 P which corresponds to the Nterminal end of the cloned domain. As the protein was expressed as a GST fusion, the peptide GSHM remains at the N terminal end after thrombin cleavage (Troffer-Charlier et al, 2007) .
CARM 28-507 crystals: MALDI peptide mass fingerprinting
Enzymatic digestion of excised bands was performed with Trypsin as previously described (Cavusoglu et al, 2003) . Peptide extracts (0.5 µl) were mixed with an equal volume of saturated 2,5-dihydroxybenzoic acid (DHB, 10mg/ml, SIGMA) dissolved in 20% acetonitrile.
Crystals were obtained by applying droplets of peptide-matrix mixtures to the target and dried at RT. MALDI MS measurements were carried out on a Bruker Reflex IV MALDI-TOF spectrometer. This instrument was used at a maximum accelerating potential of 20kV (in positive mode) and was operated in reflectron mode. The acquisition m/z range was 800-3000 with low mass gate set at 700. The internal calibration was performed using tryptic peptides (m/z=842.509 and m/z=2211.104) . Monoisotopic peptide masses were assigned using the Bruker Flex Analysis software. Peak lists were submitted to the FindMod software (http://www.expasy.org/tools) using the following parameters: the CARM 28-507 protein as the user-entered sequence; Trypsin digestion; 1 missed cleavages allowed; iodoacetamide treatment on cysteines was considered complete and methionine oxidation only partial;
tolerance: 75ppm. The bands of the purified CARM 28-507 , the crystallisation drop and the crystals were excised from a coomassie-blue stained SDS-PAGE gel (Supplementary Figure   3A) , enzymatically digested with Trypsin and subjected to MALDI mass spectrometry.
Comparative Peptide Mass Finger Printing analysis revealed no significant differences (data not shown). For each spectrum, more then 25 peaks were detected corresponding to tryptic a Native low resolution data set used for initial SIRAS phasing with the TMLA data set.
b Friedel pairs have not been merged for the TMLA data set. 
